Manel Kraiem

Company: Innate Pharma
Job title: ADC Scientific Leader, Project Manager, IPRL
Seminars:
Delving into the Newest ADC Technologies: Site-Specific Conjugation Based on Transglutaminase 12:00 pm
Explore site-specific conjugation based on bacterial transglutaminase (BTG): platforms with high potential Review site-specific conjugation of native vs silent antibodies: positive and negative aspects Focus on Innate-Pharma BTG technology Read more
day: Track A - Day 2